1. Gigantol Suppresses Cancer Stem Cell-Like Phenotypes in Lung Cancer Cells
   Narumol Bhummaphan et al, 2015, Evidence-Based Complementary and Alternative Medicine CrossRef
2. Misfolded N-CoR is Linked to the Ectopic Reactivation of CD34/Flt3-Based Stem-Cell Phenotype in Promyelocytic and Monocytic Acute Myeloid Leukemia
   Dawn Sijin Nin et al, 2015, Front. Oncol. CrossRef
3. Perturbed Signaling and Role of Posttranslational Modifications in Cancer Drug Resistance
   Suruchi Aggarwal et al, 2017 CrossRef
4. Role of the aryl hydrocarbon receptor in carcinogenesis and potential as an anti-cancer drug target
   Siva Kumar Kolluri et al, 2017, Arch Toxicol CrossRef
5. Suppression of a cancer stem-like phenotype mediated by alpha-lipoic acid in human lung cancer cells through down-regulation of β-catenin and Oct-4.
   Preeyaporn Plaimee Phiboonchaiyanan et al, 2017, Cell Oncol (Dordr) CrossRef
6. Phosphorylation of Threonine 343 Is Crucial for OCT4 Interaction with SOX2 in the Maintenance of Mouse Embryonic Stem Cell Pluripotency
   Xianmixinuer Abulaiti et al, 2017, Stem Cell Reports CrossRef
7. Dynamics of Bone Marrow VSELs and HSCs in Response to Treatment with Gonadotropin and Steroid Hormones, during Pregnancy and Evidence to Support Their Asymmetric/Symmetric Cell Divisions
   Ranita Ganguly et al, 2017, Stem Cell Rev and Rep CrossRef
8. The emerging roles of Oct4 in tumor-initiating cells
   Ying-Jie Wang et al, 2015, American Journal of Physiology-Cell Physiology CrossRef
9. Suppression of cancer stem-like phenotypes in NCI-H460 lung cancer cells by vanillin through an Akt-dependent pathway
   Songpol Srinual et al, 2017 CrossRef
10. Application of induced pluripotency in cancer studies
    Patrycja Czerwińska et al, 2018, Reports of Practical Oncology & Radiotherapy CrossRef
11. Endogenous authentic OCT4A proteins directly regulate FOS/AP-1 transcription in somatic cancer cells
    Yanwen Zhou et al, 2018, Cell Death Dis CrossRef
12. Nitric oxide promotes cancer cell dedifferentiation by disrupting an Oct4:caveolin-1 complex: A new regulatory mechanism for cancer stem cell formation
    Arnatchai Maiuthed et al, 2018, J. Biol. Chem. CrossRef
13. Aryl-hydrocarbon receptor as a potential target for anticancer therapy
    J.E. Vorontsova et al, 2018, Biomed Khim CrossRef
14. Aryl-Hydrocarbon Receptor as a Potential Target for Anticancer Therapy
    J. E. Vorontsova et al, 2019, Biochem. Moscow Suppl. Ser. B CrossRef
15. Dual inhibiting OCT4 and AKT potently suppresses the propagation of human cancer cells
    Wenxin Li et al, 2017, Sci Rep CrossRef
16. Stem Cells and Cancer Stem Cells
    Phuc Van Pham, 2015 CrossRef
17. Cancer stem cells: A review from origin to therapeutic implications.
    Mohammad Reza Atashzar et al, 2020, J Cell Physiol CrossRef
18. Ciprofloxacin mediates cancer stem cell phenotypes in lung cancer cells through caveolin-1-dependent mechanism
    Preeyaporn Plaimee Phiboonchaiyanan et al, 2016, Chemico-Biological Interactions CrossRef
19. HBx drives alpha fetoprotein expression to promote initiation of liver cancer stem cells through activating PI3K/AKT signal pathway
    Mingyue Zhu et al, 2017, Int. J. Cancer CrossRef
20. Inhibition of Fatty Acid Synthase Reduces Blastocyst Hatching through Regulation of the AKT Pathway in Pigs
    Jing Guo et al, 2017, PLoS ONE CrossRef
21. PD-L1 promotes OCT4 and Nanog expression in breast cancer stem cells by sustaining PI3K/AKT pathway activation.
    Sheema Almozyan et al, 2017, Int J Cancer CrossRef
22. Targeting annexin A2 reduces tumorigenesis and therapeutic resistance of nasopharyngeal carcinoma
    Chang-Yu Chen et al, 2015, Oncotarget CrossRef
23. The aryl hydrocarbon receptor ligand ITE inhibits cell proliferation and migration and enhances sensitivity to drug‐resistance in hepatocellular carcinoma
    Xiaoqian Zhang et al, 2020, J Cell Physiol CrossRef
24. Epigenetic Regulations of Cancer Stem Cells by the Aryl Hydrocarbon Receptor Pathway
    Sabah Akhtar et al, 2020, Seminars in Cancer Biology CrossRef
25. Tumorigenic and Immunogenic Properties of Induced Pluripotent Stem Cells: a Promising Cancer Vaccine
    Yu Qiao et al, 2020, Stem Cell Rev and Rep CrossRef
26. Targeting MYCN in Molecularly Defined Malignant Brain Tumors
    Anna Borgenvik et al, 2021, Front. Oncol. CrossRef
27. Converging Roles of the Aryl Hydrocarbon Receptor in Early Embryonic Development, Maintenance of Stemness, and Tissue Repair
    Hesbon A Zablon et al, 2021 CrossRef
28. Melatonin and its derivative disrupt cancer stem‐like phenotypes of lung cancer cells via AKT downregulation
    Preeyaporn Plaimee Phiboonchaiyanan et al, 2021, Clin Exp Pharmacol Physiol CrossRef
29. The aryl hydrocarbon receptor: A diagnostic and therapeutic target in glioma
    Ting Xiang Lim et al, 2021, Drug Discovery Today CrossRef
30. Pongol Methyl Ether Inhibits Akt and Suppresses Cancer Stem Cell Phenotypes in Lung Cancer Cells
    Arnon Silapech et al, 2021, Pharmaceuticals CrossRef
31. Sub‐chronic cadmium and lead compound exposure induces reproductive toxicity and development of testicular germ cell neoplasia in situ in murine model: Attenuative effects of resveratrol
    Sreyashi Mitra et al, 2022, J Biochem & Molecular Tox CrossRef
32. Protein Posttranslational Modification in Stemness Remodeling and Its Emerging Role as a Novel Therapeutic Target in Gastrointestinal Cancers
    Yifei Wang et al, 2023, IJMS CrossRef
33. Maternal exposure to hyperbaric oxygen at the preimplantation stages increases apoptosis and ectopic Cdx2 expression and decreases Oct4 expression in mouse blastocysts via Nrf2‐Notch1 upregulation and Nf2 downregulation
    Yu‐Ming Li et al, 2023, Developmental Dynamics CrossRef
34. Lung cancer stem cells markers and their potential therapeutic molecular targets
    Jagan Sundaram, 2024 CrossRef
35. Role of OCT4 in Glioblastoma
    Mehdi Hayat Shahi, 2023 CrossRef